New 1-(2-hydroxylaryl)-alkane-1-on-oximes, procedure for their preparation, and their applicability to pharmaceutical preparations. One purpose is to develop 1-(2-hydroxyaryl)-alkane-1-on-oximes with desirable pharmacological properties. The new compounds of Formula I ##STR1## are characterised by pharmacologically valuable properties, in particular by anti-asthmatic, anti-anaphylactic, antiphlogistic, antihypertensive, spasmolytic, antirheumatic, and antithrombotic, potentials and are applicable in human and veterinary medicine to therapy of asthma bronchiale and other allergic diseases, various kinds of inflammatory and rheumatic diseases, and thrombosis.
新的1-(2-羟基芳基)-烷基-1-酮
肟类化合物,它们的制备方法以及它们在制药方面的应用。其中一个目的是开发具有理想药理学性质的1-(2-羟基芳基)-烷基-1-酮
肟类化合物。公式I的新化合物如下:##STR1## 具有药理学上有价值的特性,特别是抗哮喘、抗过敏、抗炎、降压、解痉、抗风湿和抗血栓的潜力,并适用于人类和兽医学领域,用于治疗支气管哮喘和其他过敏性疾病、各种炎症和风湿性疾病以及血栓形成。